Want to create an interactive transcript for this episode?
Podcast: Medsider: Learn from Medtech and Healthtech Founders and CEOs
Episode: Shaping the Future of Alzheimer’s Care: Interview with Sinaptica CEO Ken Mariash
Description: In this episode of Medsider Radio, we had an enlightening conversation with Ken Mariash, a leading figure in the neuromodulation space and the CEO of Sinaptica Therapeutics, where his team is developing groundbreaking treatments for Alzheimer's disease. Their device delivers non-invasive neuromodulation therapy to key networks of the brain and has shown unprecedented improvement in treating this debilitating disease. Ken's two decades of experience leading sophisticated organizations has taken him from management consulting at Charles River Associates to significant roles at CSL, Baxter, and Boston Scientific. During his time at Boston, Ken was instrumental in commercialization and s...